| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/31/2004 | CA2141247C Process for the preparation of diacerein |
| 08/31/2004 | CA2133429C Topical administration of toremifene and its metabolites |
| 08/31/2004 | CA2098076C Imidate prodrugs of pharmaceutically useful anticonvulsant sulfamates |
| 08/28/2004 | CA2459012A1 Crystalline form z of rabeprazole sodium and process for preparation thereof |
| 08/28/2004 | CA2420180A1 Tablets comprising modafinil |
| 08/27/2004 | CA2458001A1 Regulation of immune responses by manipulation of intermediary metabolite levels |
| 08/26/2004 | WO2004072272A1 Bacterial compositions |
| 08/26/2004 | WO2004072257A2 Dyrks as modifiers of the apc and axin pathways and methods of use |
| 08/26/2004 | WO2004072255A2 Methods of treating disease |
| 08/26/2004 | WO2004072253A2 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 08/26/2004 | WO2004072243A2 Macrocyclic hepatitis c serine protease inhibitors |
| 08/26/2004 | WO2004072102A2 Benzene acetamide compounds useful as serine protease inhibitors |
| 08/26/2004 | WO2004072101A2 Phenylglycine derivatives useful as serine protease inhibitors |
| 08/26/2004 | WO2004072100A2 Nell peptide expression systems and bone formation activity of nell peptide |
| 08/26/2004 | WO2004072094A2 Hmgb1 modulator binding domain |
| 08/26/2004 | WO2004072092A1 Medicament for inhibiting tumour growth |
| 08/26/2004 | WO2004072085A2 Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations |
| 08/26/2004 | WO2004072083A1 Benzamide derivatives as oxytocin agonists and vasopressin antagonists |
| 08/26/2004 | WO2004072072A1 Triazolo-pyridines as anti-inflammatory compounds |
| 08/26/2004 | WO2004072070A1 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives |
| 08/26/2004 | WO2004072068A1 Vanilloid receptor ligands and their use in treatments |
| 08/26/2004 | WO2004072061A1 Method of stabilizing lansoprazole |
| 08/26/2004 | WO2004072056A1 Medicinal composition |
| 08/26/2004 | WO2004072049A1 Polymorph of {6,7-bis(2-methoxy-ethoxy)-quinazolin-4-yl}-(3e) |
| 08/26/2004 | WO2004072047A1 Indoles, benzimidazoles or naphhimidazoles as histone deacetylase (hdac) inhibitors |
| 08/26/2004 | WO2004072040A1 Crystalline forms of pitavastatin calcium |
| 08/26/2004 | WO2004072034A1 Piperidine-benzenesulfonamide derivatives |
| 08/26/2004 | WO2004072033A2 Pyrazoles and methods of making and using the same |
| 08/26/2004 | WO2004072030A2 Process for preparing pyrrolotriazine kinase inhibitors |
| 08/26/2004 | WO2004072029A2 Pyrazolopyridazines useful as inhibitors of protein kinases |
| 08/26/2004 | WO2004072020A1 Hydroxy-tetrahydro-naphthalenylurea derivatives |
| 08/26/2004 | WO2004072018A1 Amine derivative |
| 08/26/2004 | WO2004072017A1 Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it |
| 08/26/2004 | WO2004072016A1 Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
| 08/26/2004 | WO2004072013A1 Hydroxyeicosadienoic acid compound |
| 08/26/2004 | WO2004072010A1 Depigmentation agents |
| 08/26/2004 | WO2004071538A2 Topical delivery of cosmetic agents |
| 08/26/2004 | WO2004071534A1 Preventives/remedies for kidney diseases |
| 08/26/2004 | WO2004071533A1 Preparation for topical administration |
| 08/26/2004 | WO2004071532A1 Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses |
| 08/26/2004 | WO2004071531A1 Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia |
| 08/26/2004 | WO2004071528A1 Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 08/26/2004 | WO2004071527A1 New pharmaceutical compositions based on anticholinergics and anti-tnf antibodies |
| 08/26/2004 | WO2004071526A1 Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof |
| 08/26/2004 | WO2004071522A1 New pharmaceutical compositions based on anticholinergics and soluble tnf receptor fusion proteins |
| 08/26/2004 | WO2004071519A1 Photosynthetic micro-organisms enriched with biologically-active molecules, preparation method thereof and uses of same |
| 08/26/2004 | WO2004071516A1 Glycyrrhizine-containing percutaneous preparation |
| 08/26/2004 | WO2004071515A1 Preparation of monosaccharide derivatives |
| 08/26/2004 | WO2004071514A1 15-keto-prostaglandin derivatives for treating ocular hypertension and glaucoma |
| 08/26/2004 | WO2004071513A1 Use of r-10-hydroxy-10, 11-dihydro-carbamazepine in neuropathic pain |
| 08/26/2004 | WO2004071512A1 Application of 2-cyano-10- (2-methyl-3- (methylamino)- propyl) phenothiazine or a pharmaceutically acceptable salt as medicament |
| 08/26/2004 | WO2004071511A1 Use of cci-779 in treatment of hepatic fibrosis |
| 08/26/2004 | WO2004071510A1 Pharmaceutical composition comprising immunosuppressants for the treatment of dermatophytosis |
| 08/26/2004 | WO2004071508A1 Ip receptor antagonists for the treatment of pathological uterine conditions |
| 08/26/2004 | WO2004071507A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 08/26/2004 | WO2004071506A1 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 08/26/2004 | WO2004071504A1 Compounds which are modulators of the ppar-type receptors and their use in cosmetic or pharmaceutical compositions |
| 08/26/2004 | WO2004071503A1 Remedy for viral disease |
| 08/26/2004 | WO2004071502A1 Injectable liquid formulation of paracetamol |
| 08/26/2004 | WO2004071501A1 Enantiomeric amphetamine compositions for the treatment of adhd |
| 08/26/2004 | WO2004071500A1 Cosmetic rejuvenating and healing product, method of its manufacture and uses thereof |
| 08/26/2004 | WO2004071499A1 Diclofenac-containing plaster |
| 08/26/2004 | WO2004071496A1 Oral administration form containing liponic acid for colon-specific release of active substances |
| 08/26/2004 | WO2004071495A1 Composition for chemoembolotherapy of solid tumors |
| 08/26/2004 | WO2004071491A1 Aerosol formulations and aerosol delivery of buspirone, buprenorphine, triazolam, cyclobenzaprine and zolpidem |
| 08/26/2004 | WO2004071490A1 Solvent system of hardly soluble drug with improved elution rate |
| 08/26/2004 | WO2004071486A1 Solid amorphous mixtures, processes for the preparation thereof and pharmaceutical compositions containing the same |
| 08/26/2004 | WO2004071485A1 Surgical implant compprising an anabolic and a corticosteroid |
| 08/26/2004 | WO2004071484A1 Levamisole hydrochloride liniment |
| 08/26/2004 | WO2004071481A1 Melanogenesis inhibitor and skin preparation containing the same |
| 08/26/2004 | WO2004071477A1 Method of obtaining and treating compounds from ozonized unsaturated vegetable oils for pharmaceutical compositions for medical and veterinary use |
| 08/26/2004 | WO2004071472A1 SKIN PREPARATION FOR EXTERNAL USE CHARACTERIZED BY CONTAINING SUGAR DERIVATIVE OF α,α-TREHALOSE |
| 08/26/2004 | WO2004071468A2 Short immunomodulatory oligonucleotides |
| 08/26/2004 | WO2004071466A2 Manufacturing process for liposomal preparations |
| 08/26/2004 | WO2004071463A2 Fluoromethotrexates and uses therefor |
| 08/26/2004 | WO2004071461A2 Tra16 a tr4/tr2 repressor |
| 08/26/2004 | WO2004071460A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/26/2004 | WO2004071459A2 Methods and compositions related to irm compounds and toll-like receptor 8 |
| 08/26/2004 | WO2004071458A2 REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS |
| 08/26/2004 | WO2004071453A2 Compositions and methods for treatment of pouchitis |
| 08/26/2004 | WO2004071449A2 Lactams as modulators of chemokine receptor activity |
| 08/26/2004 | WO2004071447A2 Substituted azole derivatives as therapeutic agents |
| 08/26/2004 | WO2004071442A2 Novel bicyclic compounds and compositions |
| 08/26/2004 | WO2004071441A2 Compositions and methods to modulate immune and inflammatory responses |
| 08/26/2004 | WO2004071440A2 Thiazolyl-based compounds useful as kinase inhibitors |
| 08/26/2004 | WO2004071437A2 Compositions for enhancing sexual responsiveness |
| 08/26/2004 | WO2004071435A2 Enhanced Bioavailability Using Laser Resonant Homogenization |
| 08/26/2004 | WO2004071433A2 Methods of treating disease |
| 08/26/2004 | WO2004071432A2 Method for treating hypothyroidism |
| 08/26/2004 | WO2004071431A2 Method and composition for treating neurodegenerative disorders |
| 08/26/2004 | WO2004071430A2 RNAi TARGETING OF VIRUSES |
| 08/26/2004 | WO2004071428A2 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 08/26/2004 | WO2004071427A2 Screening and treatment methods for prevention of preterm delivery |
| 08/26/2004 | WO2004071426A2 Compounds for the treatment of viral infection |
| 08/26/2004 | WO2004071425A2 The combined use of cruciferous indoles and chelators for the treatment of papillomavirus-related conditions |
| 08/26/2004 | WO2004071424A2 Immediate release formulation of n-(2-propylpentanoyl)glycinamide |
| 08/26/2004 | WO2004071423A2 Methods of administering opioid antagonists and compositions thereof |
| 08/26/2004 | WO2004071421A2 Sustained release formulation of n-(2-propylpentanoyl) glycinamide and related compounds |
| 08/26/2004 | WO2004071419A2 Methods and compositions for modulating glutamate transport activity in the nervous system |
| 08/26/2004 | WO2004071417A2 Inhibitors of candida albicans |